Investor

Flagship Ventures

No cheque observed since Feb 2016, after 58 earlier cheques, and the website is dead.

DormantNew fund $137M, Jun 2016Accelerator

Series ASeries BSeries C

Cheques on record
0%of best year0cheques in 12 months, 58 on record
Since the last cheque3910days00hrs00min00sec
Median round$20MRounds led0 of 58Sole investor8 roundsExits8 from the portfolioMostly inUnited States, 97%
Pitch Flagship Ventures

Flagship Ventures highlights

  1. 01

    58 rounds on record

  2. 02

    Mostly Series A and Series B: 65% of its rounds

  3. 03

    Sole investor in 8 rounds, median $42M

  4. 04

    8 exits from the portfolio

What they do

Type
Accelerator (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first58 appearances

  1. 2016

    1 round

  2. Feb
    AgTech Accelerator$20MWith 9 others
  3. 2015

    9 rounds

  4. Nov
    Codiak BiosciencesSeries A · US$80MWith 2 others
  5. Nov
    Evelo TherapeuticsVenture · US$35MSole investor
  6. Oct
    TARIS BiomedicalGrowth · US$32MWith 2 others
  7. Sept
    Selecta BiosciencesSeries E · US$38MWith 7 others
  8. Aug
    Editas MedicineSeries B · US$120MWith 14 others
  9. May
    Pronutria Biosciences, Inc.Series C · US$39MWith 1 other
  10. May
    Denali TherapeuticsSeries A · US$217MWith 3 others
  11. Mar
    Red Rock BiofuelsUSUndisclosedSole investor
  12. Jan
    Blend TherapeuticsSeries B · US$21MWith 3 others
  13. 2014

    7 rounds

  14. Dec
    Seres HealthSeries C · US$48MSole investor
  15. Nov
    SymbiotaSeries A · US$7.5MSole investor
  16. Oct
    Syros PharmaceuticalsSeries B · US$53MWith 5 others
  17. Oct
    VisterraSeries B · US$30MWith 7 others
  18. Sept
    Black Duck SoftwareSeries F · US$20MWith 7 others
  19. Aug
    Seventh Sense BiosystemsSeries B · US$16MWith 4 others
  20. May
    Seres HealthSeries B · US$10MWith 3 others
  21. 2013

    3 rounds

  22. Dec
    Blend TherapeuticsSeries B · US$21MWith 2 others
  23. Dec
    PronutriaSeries B · US$12MWith 1 other
  24. Nov
    Moderna TherapeuticsGrowth · US · finsmes.com$135MSole investor
  25. 2012

    2 rounds

  26. Nov
    Tangent Medical TechnologiesSeries B · US · sec.gov$8.6MWith 2 others
  27. Jan
    Joule UnlimitedSeries C · US · jouleunlimited.com$70MSole investor
  28. 2011

    1 round

  29. Oct
    Black Duck SoftwareSeries E · US · masshightech.com$12MWith 9 others
  30. 2010

    1 round

  31. Jun
    Acceleron PharmaVenture · US$10MWith 4 others
  32. 2009

    1 round

  33. Feb
    Black Duck SoftwareSeries D · US · techcrunch.com$5.0MWith 9 others
  34. 2008

    6 rounds

  35. Aug
    QuanterixSeries A · US · equityhelpdesk.com$15MWith 2 others
  36. Jul
    Accuri CytometersSeries C · US · sec.gov$13MWith 3 others
  37. Jul
    Agios PharmaceuticalsSeries A · US$33MWith 2 others
  38. Jul
    BG MedicineSeries D · US · liquidscenarios.com$41MWith 3 others
  39. May
    Jinko Solar HoldingSeries A · CNUndisclosedSole investor
  40. Apr
    VisEn MedicalSeries B · US$5.0MWith 3 others
  41. 2007

    5 rounds

  42. Nov
    BIND TherapeuticsSeries B · US$16MWith 3 others
  43. Nov
    Ensemble DiscoverySeries B · US$15MWith 6 others
  44. Jul
    Ze-genSeries A · US$4.5MWith 1 other
  45. Feb
    Everyday WirelessSeries A · US$6.8MSole investor
  46. Feb
    BIND BiosciencesSeries A · US$2.5MWith 1 other
  47. 2006

    1 round

  48. Nov
    Tetraphase PharmaceuticalsSeries A · US$10MWith 4 others
  49. 2005

    2 rounds

  50. Dec
    Resolvyx PharmaceuticalsSeries A · US$17MWith 2 others
  51. Jun
    BrainsharkSeries C · US$6.9MWith 4 others
  52. 2004

    7 rounds

  53. Sept
    SiCortexSeries A · US$21MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

NBNoubar B. Afeyan, Ph.D.Executive OfficeriFiling they signed

We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed8 in all

Agios PharmaceuticalsListed$86MJun 2013
Accuri CytometersBought by (Becton, Dickinson and Company)UndisclosedMar 2011
AdnexusBought by Bristol-Myers Squibb$415MAug 2010
CGI PharmaceuticalsBought by Gilead Sciences$120MJun 2010
AVEO PharmaceuticalsListedUndisclosedMar 2010
NuVoxBought by Windstream$643MNov 2009
AdnexusBought by Bristol-Myers Squibb$415MSept 2007
HypnionBought by LillyUndisclosedApr 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Flagship Ventures. A count of rooms they were both in, not a relationship either has claimed.

Mentioned on podcasts

Episodes that name Flagship Ventures in their description, not their title.

Quick answers about Flagship Ventures

What does Flagship Ventures invest in?

Flagship Ventures invests most often at Series A and Series B (65% of the rounds on record).

How active is Flagship Ventures?

58 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2016.

What has Flagship Ventures invested in recently?

Its most recent investments on record: AgTech Accelerator (Feb 2016).

How big are Flagship Ventures's cheques?

The median round it joins is $20M.

Does Flagship Ventures lead rounds?

Rarely, if at all: none of its 58 investments on record names it as the lead.

Where does Flagship Ventures invest?

Most of the companies it backs are in the United States (97%).

Is Flagship Ventures investing now?

It looks quiet: no investment on record since Feb 2016.

Who does Flagship Ventures invest alongside?

Most often Polaris Partners (12 rounds together), ARCH Venture Partners (8 rounds together) and Alexandria Real Estate Equities (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it